US 11464768
Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
granted A61KA61K31/13A61K31/135
Quick answer
US patent 11464768 (Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis) held by ACADIA Pharmaceuticals Inc. expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/13, A61K31/135, A61K31/27, A61K31/343